Core Laboratories (CLB) Set to Announce Earnings on Wednesday

Core Laboratories (NYSE:CLB) will release its earnings data after the market closes on Wednesday, October 23rd. Analysts expect Core Laboratories to post earnings of $0.21 per share for the quarter. Core Laboratories has set its Q3 2024 guidance at 0.230-0.270 EPS and its Q3 guidance at $0.23-0.27 EPS.Persons that wish to listen to the company’s earnings conference call can do so using this link.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings data on Wednesday, July 24th. The oil and gas company reported $0.22 earnings per share for the quarter, topping analysts’ consensus estimates of $0.21 by $0.01. Core Laboratories had a return on equity of 15.20% and a net margin of 5.44%. The firm had revenue of $130.58 million for the quarter, compared to analyst estimates of $132.85 million. During the same period last year, the company earned $0.23 EPS. The business’s quarterly revenue was up 2.1% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Core Laboratories Price Performance

CLB opened at $18.63 on Tuesday. The stock’s 50 day moving average price is $18.66 and its 200-day moving average price is $18.96. Core Laboratories has a 52-week low of $13.82 and a 52-week high of $25.13. The stock has a market capitalization of $873.75 million, a PE ratio of 21.17, a price-to-earnings-growth ratio of 1.08 and a beta of 2.36. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.68 and a current ratio of 2.39.

Core Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 26th. Shareholders of record on Monday, August 5th were given a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.21%. The ex-dividend date of this dividend was Monday, August 5th. Core Laboratories’s payout ratio is currently 4.55%.

Analysts Set New Price Targets

A number of equities research analysts have recently weighed in on CLB shares. Stifel Nicolaus lifted their target price on shares of Core Laboratories from $18.00 to $22.00 and gave the company a “hold” rating in a research note on Friday, July 26th. Bank of America cut their price objective on Core Laboratories from $16.00 to $15.00 and set an “underperform” rating on the stock in a research report on Monday, July 15th. Piper Sandler reduced their target price on Core Laboratories from $18.00 to $17.00 and set a “neutral” rating on the stock in a report on Monday, July 15th. Finally, StockNews.com cut Core Laboratories from a “hold” rating to a “sell” rating in a research note on Tuesday, September 17th. Two investment analysts have rated the stock with a sell rating and two have issued a hold rating to the stock. According to data from MarketBeat.com, Core Laboratories has an average rating of “Hold” and an average price target of $18.00.

Core Laboratories Company Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.